Delayed‑release mercaptamine approved for routine use
News
Fridge‑free vaccine shows global potential
Stablepharma’s thermostable td shot delivers strong phase 1 data
Lexeo wins FDA RMAT status for LX2020
Regulator backs gene therapy for PKP2-ACM
EHP Awards 2027 open for entries
Programme celebrates partnership excellence
NICE backs new blood cancer regimens
Acalabrutinib combinations approved for CLL and MCL
Obsidian begins registration cohort for amsoki-cel
First patient enrolled in Agni-01 expansion
Entera Bio data selected for ASBMR plenary session
Postmenopausal study highlights oral anabolic potential
NHS backs delayed‑release treatment for cystinosis
Decision expands options for eligible patients
Oblenio doses first patients in phase 1a autoimmune trial
Study evaluates tri‑specific T cell engager LBL‑051
BeOne Medicines secures UK innovation passport for HCC therapy
Designation supports accelerated access for investigational antibody
Sanofi’s MenQuadfi approved for EU infants
EC expands use to protect youngest children
Qnovia licenses novel antimicrobial peptide
New therapy aims to tackle antibiotic resistance
Lexeo wins FDA RMAT status for LX2020
Regulator backs gene therapy for PKP2-ACM
Polpharma Biologics gains FDA and EMA review acceptances
Regulators assess PB016 vedolizumab biosimilar applications
Parsortix study shows promise for ADC target detection
Researchers highlight minimally invasive monitoring potential
